Literature DB >> 27453361

Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies.

Marc Lipsitch1, Ayan Jha1,2, Lone Simonsen3,4.   

Abstract

Although randomized placebo-controlled trials (RCT) are critical to establish efficacy of vaccines at the time of licensure, important remaining questions about vaccine effectiveness (VE)-used here to include individual-level measures and population-wide impact of vaccine programmes-can only be answered once the vaccine is in use, from observational studies. However, such studies are inherently at risk for bias. Using a causal framework and illustrating with examples, we review newer approaches to detecting and avoiding confounding and selection bias in three major classes of observational study design: cohort, case-control and ecological studies. Studies of influenza VE, especially in seniors, are an excellent demonstration of the challenges of detecting and reducing such bias, and so we use influenza VE as a running example. We take a fresh look at the time-trend studies often dismissed as 'ecological'. Such designs are the only observational study design that can measure the overall effect of a vaccination programme [indirect (herd) as well as direct effects], and are in fact already an important part of the evidence base for several vaccines currently in use. Despite the great strides towards more robust observational study designs, challenges lie ahead for evaluating best practices for achieving robust unbiased results from observational studies. This is critical for evaluation of national and global vaccine programme effectiveness.
© The Author 2016; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.

Keywords:  case-control studies; ecological study; epidemiologic methods; negative control; observational studies; test-negative design

Mesh:

Substances:

Year:  2016        PMID: 27453361      PMCID: PMC5841615          DOI: 10.1093/ije/dyw124

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  81 in total

1.  Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans.

Authors:  J Nordin; J Mullooly; S Poblete; R Strikas; R Petrucci; F Wei; B Rush; B Safirstein; D Wheeler; K L Nichol
Journal:  J Infect Dis       Date:  2001-08-09       Impact factor: 5.226

2.  Impact of influenza vaccination on seasonal mortality in the US elderly population.

Authors:  Lone Simonsen; Thomas A Reichert; Cecile Viboud; William C Blackwelder; Robert J Taylor; Mark A Miller
Journal:  Arch Intern Med       Date:  2005-02-14

3.  Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results.

Authors:  Edward A Belongia; Burney A Kieke; James G Donahue; Laura A Coleman; Stephanie A Irving; Jennifer K Meece; Mary Vandermause; Stephen Lindstrom; Paul Gargiullo; David K Shay
Journal:  Vaccine       Date:  2011-07-19       Impact factor: 3.641

4.  Waning protection after fifth dose of acellular pertussis vaccine in children.

Authors:  Nicola P Klein; Joan Bartlett; Ali Rowhani-Rahbar; Bruce Fireman; Roger Baxter
Journal:  N Engl J Med       Date:  2012-09-13       Impact factor: 91.245

5.  The Japanese experience with vaccinating schoolchildren against influenza.

Authors:  T A Reichert; N Sugaya; D S Fedson; W P Glezen; L Simonsen; M Tashiro
Journal:  N Engl J Med       Date:  2001-03-22       Impact factor: 91.245

6.  Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.

Authors:  Danuta M Skowronski; Gaston De Serres; Natasha S Crowcroft; Naveed Z Janjua; Nicole Boulianne; Travis S Hottes; Laura C Rosella; James A Dickinson; Rodica Gilca; Pam Sethi; Najwa Ouhoummane; Donald J Willison; Isabelle Rouleau; Martin Petric; Kevin Fonseca; Steven J Drews; Anuradha Rebbapragada; Hugues Charest; Marie-Eve Hamelin; Guy Boivin; Jennifer L Gardy; Yan Li; Trijntje L Kwindt; David M Patrick; Robert C Brunham
Journal:  PLoS Med       Date:  2010-04-06       Impact factor: 11.069

7.  Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil.

Authors:  Jailson B Correia; Manish M Patel; Osamu Nakagomi; Fernanda M U Montenegro; Eliane M Germano; Nancy B Correia; Luis E Cuevas; Umesh D Parashar; Nigel A Cunliffe; Toyoko Nakagomi
Journal:  J Infect Dis       Date:  2010-02-01       Impact factor: 5.226

8.  Effect of rotavirus vaccination on death from childhood diarrhea in Mexico.

Authors:  Vesta Richardson; Joselito Hernandez-Pichardo; Manjari Quintanar-Solares; Marcelino Esparza-Aguilar; Brian Johnson; Cesar Misael Gomez-Altamirano; Umesh Parashar; Manish Patel
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

9.  Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015.

Authors:  Rodica Gilca; Danuta M Skowronski; Monique Douville-Fradet; Rachid Amini; Nicole Boulianne; Isabelle Rouleau; Christine Martineau; Hugues Charest; Gaston De Serres
Journal:  PLoS One       Date:  2015-07-22       Impact factor: 3.240

10.  Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic.

Authors:  Michael L Jackson; Onchee Yu; Jennifer C Nelson; Allison Naleway; Edward A Belongia; Roger Baxter; Komal Narwaney; Steven J Jacobsen; David K Shay; Lisa A Jackson
Journal:  Am J Epidemiol       Date:  2013-08-26       Impact factor: 4.897

View more
  43 in total

Review 1.  Improving vaccine trials in infectious disease emergencies.

Authors:  Marc Lipsitch; Nir Eyal
Journal:  Science       Date:  2017-07-14       Impact factor: 47.728

2.  Estimating the population-level impact of vaccines using synthetic controls.

Authors:  Christian A W Bruhn; Stephen Hetterich; Cynthia Schuck-Paim; Esra Kürüm; Robert J Taylor; Roger Lustig; Eugene D Shapiro; Joshua L Warren; Lone Simonsen; Daniel M Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-01       Impact factor: 11.205

3.  Effectiveness of influenza vaccination on influenza-associated hospitalisations over time among children in Hong Kong: a test-negative case-control study.

Authors:  Shuo Feng; Susan S Chiu; Eunice L Y Chan; Mike Y W Kwan; Joshua S C Wong; Chi-Wai Leung; Yiu Chung Lau; Sheena G Sullivan; J S Malik Peiris; Benjamin J Cowling
Journal:  Lancet Respir Med       Date:  2018-11-12       Impact factor: 30.700

4.  Measurement of Vaccine Direct Effects Under the Test-Negative Design.

Authors:  Joseph A Lewnard; Christine Tedijanto; Benjamin J Cowling; Marc Lipsitch
Journal:  Am J Epidemiol       Date:  2018-12-01       Impact factor: 4.897

5.  Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic.

Authors:  Kylie E C Ainslie; Michael Haber; Walter A Orenstein
Journal:  Vaccine       Date:  2019-03-02       Impact factor: 3.641

6.  Challenges in estimating influenza vaccine effectiveness.

Authors:  Kylie E C Ainslie; Michael Haber; Walt A Orenstein
Journal:  Expert Rev Vaccines       Date:  2019-05-31       Impact factor: 5.217

7.  On the bias of estimates of influenza vaccine effectiveness from test-negative studies.

Authors:  Kylie E C Ainslie; Meng Shi; Michael Haber; Walter A Orenstein
Journal:  Vaccine       Date:  2017-11-13       Impact factor: 3.641

8.  Comparison of two control groups for estimation of oral cholera vaccine effectiveness using a case-control study design.

Authors:  Molly F Franke; J Gregory Jerome; Wilfredo R Matias; Ralph Ternier; Isabelle J Hilaire; Jason B Harris; Louise C Ivers
Journal:  Vaccine       Date:  2017-09-12       Impact factor: 3.641

9.  Uses of pathogen detection data to estimate vaccine direct effects in case-control studies.

Authors:  Joseph A Lewnard
Journal:  J R Soc Interface       Date:  2020-08-12       Impact factor: 4.118

10.  Heterogeneity in Estimates of the Impact of Influenza on Population Mortality: A Systematic Review.

Authors:  Li Li; Jessica Y Wong; Peng Wu; Helen S Bond; Eric H Y Lau; Sheena G Sullivan; Benjamin J Cowling
Journal:  Am J Epidemiol       Date:  2018-02-01       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.